CARRIE GOODWIN: Open Payments
NPI 1821600594 · GOWRIE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 16 payments from 8 companies in 2025. Trend: 2023 $276 · 2024 $410 · 2025 $435
Food & beverage: $435
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $134 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Corium, LLC | 1 | $20 |
| Alkermes, Inc. | 1 | $14 |
Products named: FANAPT, COBENFY, Qelbree, Jornay PM, AUSTEDO XR, TRINTELLIX, Azstarys, UZEDY.
Industry payments across IA — which companies pay providers there.
